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ABSTRACT We present a method that makes it possible to trigger, observe, and quantify membrane aggregation and fusion
of giant liposomes in microﬂuidic chambers. Using electroformation from spin-coated ﬁlms of lipids on transparent indium tin
oxide electrodes, we formed two-dimensional networks of closely packed, surface-attached giant liposomes. We investigated
the effects of fusogenic agents by simply ﬂowing these molecules into the chambers and analyzing the resulting shape changes
of more than 100 liposomes in parallel. We used this setup to quantify membrane fusion by several well-studied mechanisms,
including fusion triggered by Ca21, polyethylene glycol, and biospeciﬁc tethering. Directly observing many liposomes simul-
taneously proved particularly useful for studying fusion events in the presence of low concentrations of fusogenic agents, when
fusion was rare and probabilistic. We applied this microﬂuidic fusion assay to investigate a novel 30-mer peptide derived from a
recently identiﬁed human receptor protein, B5, that is important for membrane fusion during the entry of herpes simplex virus
into host cells. This peptide triggered fusion of liposomes at an ;6 times higher probability than control peptides and caused
irreversible interactions between adjacent membranes; it was, however, less fusogenic than Ca21 at comparable concen-
trations. Closely packed, surface-attached giant liposomes in microﬂuidic chambers offer a method to observe membrane
aggregation and fusion in parallel without requiring the use of micromanipulators. This technique makes it possible to char-
acterize rapidly novel fusogenic agents under well-deﬁned conditions.
INTRODUCTION
The fusion of biological membranes is crucial for life (1):
viral fusion, exocytosis, organelle fusion, and fertilization of
an oocyte are examples of biological processes that involve
the merging of closed membranes. To study the molecular
machinery and processes that govern the wide range of
fusion events, cellular assays as well as assays in reconsti-
tuted systems can yield important insight and may ultimately
lead to approaches to interfere with fusion processes for
therapeutic purposes (2). Here, we describe a versatile and
practical fusion assay that proceeds in microﬂuidic chambers
and makes it possible to investigate individual components
of the fusion machinery under well-deﬁned and variable
conditions.
Membrane fusion typically involves three conserved steps:
i), close contact between two membranes (3); ii), initial merg-
ing of the membranes, often associated with a hemifusion
state (4); and iii), opening of an aqueous fusion pore (5). In
living cells, membrane fusion is facilitated by proteins. Intra-
cellular fusion of membranes involves the tethering of mem-
branes by Rab proteins and the formation of SNARE (soluble
N-ethylmaleimide sensitive factor attachment protein recep-
tor) complexes to induce fusion (6,7). Fusion by viruses can
be mediated by fusion peptides which are typically 15–30
amino acids long. When activated, these peptides insert into
the target membrane and trigger fusion (8,9). The regulation
of the interactions between proteins, lipids, and other
molecules in these cellular processes is complex. Artiﬁcial
lipid membranes, in contrast, offer systems for studying
individual parameters involved in membrane fusion and for
determining minimal models of this process (10–12). Weber
et al. showed that complementary SNARE proteins recon-
stituted into separate liposomes were sufﬁcient to induce
fusion (13). Other studies employing artiﬁcial vesicles have
shown that a range of external factors affect fusion, including
mechanical stress (14–16), divalent and trivalent cations (17–
19), long-chain polymers (20,21), high-strength electric ﬁelds
(22), and membrane curvature (23–26).
Several techniques have been developed to investigate
membrane fusion in artiﬁcial systems. Fusion assays typically
assess the mixing of lipids and of the contents of liposomes
when fusogenic agents are added. These measurements usually
employ small liposomes (typically ,200 nm) with high
radii of curvature and utilize ﬂuorescence techniques (27–
30), light scattering (31), or electron microscopy (32,33) for
detection. In these assays, the size of liposomes affects
fusion; recently, Nomura et al. reported that the hemagglu-
tinin (HA) fusion peptide promoted fusion of liposomes with
diameters ,200 nm but did not induce fusion of giant
liposomes (34).
Fusion assays using cell-sized, giant liposomes allow
microscopic observation of membrane fusion and assess-
ments of mixing of lipids and contents. Such experiments
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typically use micropipette techniques to bring two liposomes
into close contact (17,35). For this approach, liposomes
adhere to a micropipette through suction (36), and microma-
nipulators position the micropipettes to establish contact
between two liposomes (37–39). Other methods have utilized
electrophoresis to fuse oppositely charged liposomes (40),
dielectrophoresis to bring liposomes together for electrofusion
(41), or a mixing chamber (34). Here we present a method that
affords fusion assays with the following ﬁve characteristics:
i), it enables direct visualization of membrane aggregation and
fusion of cell-sized liposomes in a microﬂuidic chamber; ii), it
monitors hundreds of membrane-membrane contacts in par-
allel; iii), it allows controlled triggering of fusion by biolog-
ically relevant mechanisms under physiological conditions
without the need for manual control; iv), it investigates fusion
of lipid membranes of well-deﬁned composition in the ab-
sence or presence of fusogenic agents; and v), it provides the
opportunity to vary the composition of the aqueous environ-
ment in which the fusion process occurs.
In previous work, Chiu et al. trapped two cells or liposomes
in a microﬂuidic system (by optical trapping, dielectrophoresis,
or micromanipulation) and used high-strength electric ﬁelds
(E . 100 kVm1) to fuse the cells (41–44). We adopted a
different approach to obtain giant liposomes in close contact by
drawing upon techniques recently developed in our lab: we
formed densely packed networks of surface-attached giant
liposomes in ﬂow chambers (45,46). These liposome networks
allowed the introduction of fusogenic molecules to the lipo-
somes in the ﬂow chambers and provided a means to visualize
fusion events directly in an optically transparent setup. Unlike
most fusion assays with giant liposomes, this setup made it
possible to observe many membrane-membrane interactions in
parallel. Moreover, it required no micromanipulators to bring
liposomes into close contact. We validated this microﬂuidic
fusion assay by triggering fusion with well-studied fusogenic
agents such as calcium ions and polyethylene glycol (PEG).
We then reconstituted a minimal model of protein-mediated
fusion that was based on biospeciﬁc interaction between mem-
branes. Finally, we demonstrate the usefulness of this tech-
nology by performing a fusion assay on a recently characterized
peptide that is involved in the entry of herpes simplex virus
(HSV) into host cells. The results show that triggering mem-
brane fusion in microﬂuidic chambers under well-deﬁned
conditions can yield important insight into the fusogenic
properties of novel molecules.
MATERIALS AND METHODS
Preparation of a microﬂuidic setup
for fusion assays
The microﬂuidic setup used in this work consisted of four parallel ﬂow
chambers in which we formed surface-attached giant liposomes (Fig. 1).
Detailed methods for fabrication have been described previously (45).
Brieﬂy, we embedded four pieces of silicone tubing (inside diameter ¼
0.60 mm, Dow Corning, Midland, MI) in a slab of 2.1-mm-thick
poly(dimethylsiloxane) (PDMS, Sylgard 184 Silicone, Dow Corning) (47) and
extracted four rectangular chambers (29.1 mm 3 3.24 mm 3 2.22 mm,
volume ¼ 209 mL) using a surgical blade. This PDMS structure was
sandwiched between two large aluminosilicate glass slides (50 mm 3 50
mm 3 1.1 mm) covered each with a surface of indium tinoxide (ITO, R, ¼
5-15 ohms. Delta Technologies, Stillwater, MN). The assembly was held
together by binder clips (Ofﬁcemate International, Edison, NJ) (Fig. 1).
Before assembly of the setup, we prepared ﬁlms of lipids by spin coating
(46). Solutions of 3.75 mg mL1 lipids (mixtures of L-a-phosphatidylcho-
line (egg, chicken) (eggPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line (POPC), 1-palmitoyl-2-oleoyl-sn-glycero-[phospho-rac-(1-glycerol)]
(POPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE),
and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-(cap piotinyl) (so-
dium salt) (N-cap biotin-PE) all from Avanti Polar Lipids, Alabaster, AL) in
95% chloroform (Acros Organics, Morris Plains, NJ), 5% acetonitrile (Acros
Organics, Geel, Belgium) were spin coated onto ITO at a speed of 600 rpm for
100 s. Films of lipid were dried under vacuum (740 mTorr) for 2 h to remove
traces of solvent. We used the same PDMS ﬂow chambers in all experiments
with the wash protocols for the PDMS ﬂow chambers and the plates of ITO as
described previously (45,46).
Formation of giant liposomes in
microﬂuidic chambers
We employed electroformation, a technique developed by Angelova and
Dimitrov, to form giant liposomes (48,49). Application of alternating current
(AC) voltages to electrodes with ﬁlms of lipids on their surface induces the
swelling of giant, unilamellar liposomes from the lipid ﬁlm (50,51). We
hydrated the spin-coated ﬁlm of lipids in the ﬂow chambers by ﬁlling, in
succession, each chamber with solution while applying an AC voltage of 1.6
V peak-to-peak (Vpp) at a frequency of 10 Hz using a function generator
FIGURE 1 Microﬂuidic setup for forming surface-attached giant lipo-
somes and triggering fusion of these liposomes. A PDMS spacer with
embedded silicone tubing leading into and out of four parallel ﬂow chambers
was sandwiched between two glass plates each covered with a surface of
ITO. Films of lipids were spin coated onto the surfaces of ITO before
assembly of the setup. Giant liposomes were formed by electroformation
after ﬁlling the chambers with solution. An AC electric ﬁeld was applied to
the ITO surfaces over 2 h to form liposomes. This setup was optically
transparent and allowed the introduction of new solutions to the chambers at
deﬁned ﬂow rates using a microprocessor-controlled syringe pump.
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(Circuitmate FG2, Beckman Coulter, Fullerton, CA) attached to the ITO
electrodes. We allowed electroformation to proceed for 2 h before turning
off the electric ﬁeld.
Flow procedures for triggering fusion
To replace solutions inside the ﬂow chambers, we used a programmable
syringe pump (KD Scientiﬁc, Holliston, MA) to drive ﬂuid ﬂow at volu-
metric ﬂow rates below 5.0 mL h1. For experiments involving Ca21-
induced fusion, we formed giant liposomes from 90% POPC, 10% POPE in
solutions of 0.1 mM Tris (hydroxymethyl) aminomethane (Tris, Shelton
Scientiﬁc, Shelton, CT) buffer pH 7.4. We then introduced 0–100 mM solu-
tions of CaCl2 (EMD Chemicals, Gibbstown, NJ) that contained 0.1 mM
Tris buffer at a rate of 2.6 mL h1 to induce fusion.
To examine two-dimensional aggregation of giant liposomes, we formed
giant liposomes composed of 100% eggPC in solutions of glycerol that were
isoosmolar to the CaCl2 to be introduced to the chamber. Solutions of CaCl2
(ranging from 0.1 mM to 200 mM) were ﬂowed through the chamber of
liposomes for 1 h at rates ,4.0 mL h1.
For experiments with poly-ethylene glycol (PEG), we employed giant
liposomes composed of 90% POPC, 10% POPE. To examine PEG-induced
fusion with osmotic mismatches between the inside and outside of liposomes,
we formed giant liposomes in 0.1 mMTris buffer pH 7.4 and introduced 1, 5,
and 10 mM PEG-6000 (Calbiochem, San Diego, CA) at 2.0 mL h1 for 1 h.
We also performed experiments with osmotically matched solutions of PEG-
6000. Using an osmometer (Model 3320, Advanced Instruments, Norwood,
MA) to match osmolalities, we formed giant liposomes in solutions of 1, 10,
and 38 mM sucrose (EM Industries, Gibbstown, NJ) and then introduced
to the chambers 1, 5, and 10 mM PEG-6000, respectively (see Fig. S3 for
osmolality concentration curves for PEG-6000 and sucrose). Finally, to
compare PEG-6000 to the other fusogenic molecules used in this assay, we
introduced 25 mM PEG-6000 in 0.013 phosphate buffered saline (PBS) to
giant liposomes prepared exactly as described below for experiments with the
fusion peptide.
For experiments involving ‘‘receptor-mediated’’ fusion, we formed giant
liposomes composed of 95% POPC, 5% biotinyl-PE in deionized H2O
(diH2O). We introduced 1.67 mM NeutrAvidin biotin-binding protein (Mo-
lecular Probes, Eugene, OR) dissolved in diH2O at a rate of 2.5 mL h
1 to
induce fusion.
Fusion assay with peptide from B5 protein
We performed a fusion assay with a synthetic peptide from the C-terminus of
the B5 receptor protein that can facilitate entry of HSV into host cells (52).
This 30-amino acid peptide (denoted WT-B5 peptide), corresponded to
amino acids 344–374 (KQQWQQLYDTLNAWKQNLNKVKNSLLSLSD)
of the B5 protein. It was synthesized and puriﬁed to 98% by the University
of Michigan protein core facility (52). The peptide was acetylated at the
N-terminus, amidated at the C-terminus, and dissolved in PBS to a con-
centration of 2.5 mM. We used two other peptides as control peptides in the
fusion assay, the oxidized chain B of insulin from bovine pancreas (Sigma,
St. Louis, MO) and human adrenocorticotropic hormone (ACTH) resi-
dues 1–24 (AnaSpec, San Jose, CA), dissolved in diH2O without further
modiﬁcation.
For all fusion assays with WT-B5 peptide, giant liposomes composed of
90% POPC, 10% POPE were formed in 0.1 mM Tris buffer pH 7.4. We
prepared solutions ofWT-B5 peptide by diluting the stock solutions (2.5 mM
WT-B5 peptide in PBS) in diH2O. In the case of oxidized chain B of insulin
and ACTH (1–24), we added PBS to the diluted solutions to match the
osmolarity and ionic strength of the solutions of WT-B5 peptide at a given
concentration of peptide. Before introducing the solutions of peptides to the
liposomes, we ﬂowed solutions of PBS through the chamber of liposomes at
2.5 mL h1 for 1 h to replace the Tris buffer inside and outside of the
surface-attached liposomes; we demonstrated previously that new solutions
introduced to surface-attached giant liposomes replace the previous solution
both outside and inside the liposomes (45). These solutions were isoosmolar
to the solution of peptide to be introduced, thus ensuring that osmolarity
differences were not a factor in the fusion assay. After ﬁlling the chambers
with PBS, we introduced the peptide solutions to the chambers at a rate of
2.5 mL h1 for 1 h for all experiments.
Observation and quantiﬁcation of fusion
We observed giant liposomes and membrane fusion by phase contrast mi-
croscopy using an inverted microscope (Eclipse TE 2000-U, Nikon, Melville,
NY) with 103 and 203 objectives with extra long working distance in
phase-contrast mode. We captured images and movies of liposomes using a
charge-coupled device camera (Photometrics CoolSnap HQ, Roper Scien-
tiﬁc, Trenton, NJ). Image analysis software (Metamorph from Universal
Imaging Corporation, Downington, PA) allowed for determination of the size
of liposomes. Fusion events were observable and could be quantiﬁed by
visually examining movies frame-by-frame for the occurrence of merging of
liposomes (see Supplementary Material for movies).
In the fusion assay for the WT-B5 peptide, precautions were taken to
ensure that similar experimental conditions (with respect to the number,
average diameter, and curvature of liposomes in the ﬁeld of view) were used
(see Supplementary Material, Fig. S4). In each experiment, we chose regions
of initially spherical liposomes (consisting of 100–120 closely packed
liposomes). We acquired movies of each peptide solution that was intro-
duced to the liposomes. For analyses, we visually counted the number of
fusion events (a fusion event was deﬁned as two liposomes merging into a
new liposome with a larger diameter than each of the initial two liposomes),
as well as the time of the event and the diameter of liposomes that fused. We
deﬁned the metric ‘‘probability of fusion’’ as the number of liposomes that
fused divided by the total number of liposomes in the ﬁeld of view; we used
this value to compare results between fusion experiments.
To quantify two-dimensional aggregation of giant liposomes (e.g., in the
case of Ca21-induced aggregation), we developed an image-processing
algorithm using the PERL language (see Supplementary Material for
detailed discussion of algorithm). This image-processing program analyzed
phase-contrast micrographs of surface-attached giant liposomes and returned
the value of ‘‘percentage of shared membrane’’ for the image. This metric
was deﬁned as the average percentage of each liposome that was directly in
contact with adjacent liposomes.
RESULTS AND DISCUSSION
Formation of networks of surface-attached giant
liposomes in microﬂuidic chambers
We formed cell-sized giant liposomes in transparent ﬂow
chambers by electroformation from spin-coated ﬁlms of
lipids on ITO electrodes (46). By growing liposomes from
uniform ﬁlms of lipids with optimal thickness, we obtained
densely packed networks of giant liposomes (in which most
liposomes were in close contact with several neighbors)
across the entire surfaces of formation (Fig. 2 A) (45). We did
not detach the liposomes; detachment is typically performed
by applying a low frequency AC electric ﬁeld (53). Instead,
the giant liposomes remained afﬁxed to the ﬁlm of lipids on
the surface of ITO by lipid tethers (45) even when exposed
to ﬂow. This experimental approach made it possible to
monitor, in parallel, many membrane-membrane contacts
between giant liposomes using a phase-contrast microscope.
Additionally, we were able to observe the same region of
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liposomes upon introduction of new solutions to the ﬂow
chambers to follow directly the effect of the introduced mole-
cules on membrane-membrane interactions and fusion. We
used this setup in all subsequent fusion assays.
Ca21-induced fusion of giant liposomes
The ﬂuidic setup presented here made it possible to rapidly
investigate several fusogenic agents by simply ﬂowing in
solutions of the molecules and analyzing the resulting shape
changes of the liposomes. To test the microﬂuidic fusion
assay on a well-known process, we introduced Ca21 ions to
giant liposomes in the ﬂow chamber. Calcium ions bind to
the phosphate group of phospholipids, thus reducing charges
at the surface of liposomes and promoting aggregations (54–
56). In addition, Ca21 can bridge the headgroups of adja-
cent vesicles and promote fusion through the creation of
‘‘defects’’ in neighboring bilayers (57). The formation of
these defects, and hence fusion, is stochastic (57,58). When
we introduced 25 mM CaCl2 to giant liposomes, 17% of all
liposomes in the ﬁeld of view (total 164 with an average
diameter of 30.6 6 11.5 mm) fused within 1 h (see Sup-
plementary Movie S1 for this Ca21-induced fusion). Most
fusion events (85%) occurred in the ﬁrst 8 min of ﬂow (Fig.
2). In comparison, introducing 5 mM CaCl2 triggered fusion
of only 1.6% of liposomes (observing 128 liposomes with an
average diameter of 33.4 6 10.0 mm). These low probabil-
ities of fusion highlight an advantage of directly examining
many membrane-membrane interactions in parallel (59,60).
Two-dimensional aggregation of giant liposomes
Membrane fusion is preceded by close contact between
adjacent membranes. Therefore, the tendency of membranes
to aggregate in the absence or presence of ‘‘membrane-
active’’ molecules is important to evaluate membrane-
membrane interactions and fusion. We found that after
introducing 25 mM CaCl2 to giant liposomes and after the
concomitant fusion of 17% of the liposomes, ;15% of
liposomes underwent ‘‘two-dimensional aggregation’’ (Fig.
2 A, right hand side). In the context of this work, we deﬁned
two-dimensional aggregation as the changes in shape of
surface-attached giant liposomes to increase contacts with
neighboring liposomes (with all the liposomes imaged in the
same two-dimensional plane, Fig. 2). These increased inter-
actions had three characteristics: 1), the number of vesicle-
vesicle contacts between liposomes that were initially not in
contact increased (Supplementary Material, Fig. S1B); 2),
vesicles adhered to one another (Supplementary Material,
Fig. S1B); and 3), contact points between liposomes extended
into deﬁned lines (Fig. 3, C and E).
To examine this two-dimensional aggregation, we quanti-
ﬁed the interactions between surface-attached giant liposomes
in solutions of 0–200 mM CaCl2 (Fig. 3). We developed
an image processing algorithm to compute ‘‘percentage of
shared membrane’’, which represents the average percentage
of each visible liposome membrane in contact with adjacent
liposome membranes (see Supplementary Material for a full
discussion of image processing techniques). This quantiﬁca-
tion showed that giant liposomes exhibited signiﬁcant two-
dimensional aggregation between 100 mM and 1 mM CaCl2
and also at CaCl2 concentrations higher than 200 mM (Fig. 3
A). Interestingly, liposomes did not aggregate at an interme-
diate concentration of 10 mM CaCl2 (Fig. 3 D), presumably
due to binding of sufﬁcient Ca21 to the headgroups of lipids
to induce positive-charge repulsion between bilayers (61).
By quantifying interactions between giant liposomes, we
were able to compare this two-dimensional assay to other
three-dimensional techniques. Previously, Akashi et al. moni-
tored the adhesion of pairs of giant liposomes composed of
FIGURE 2 Triggering fusion by introducing fusogenic molecules to
surface-attached giant liposomes. (A) Ca21-induced fusion: the introduction
of 25 mM CaCl2 promoted the fusion of 17% liposomes (composed of 90%
POPC, 10% POPE) in the ﬁeld of view. The arrows show the merging
liposomes before introduction of Ca21 (left column) and after 260 s of ﬂow
with a ﬂow rate of 2.6 mL h1 (right column). (B) Fusion triggered by a
hydrophilic polymer: Flowing 10 mM PEG-6000 into the chamber induced
the fusion of liposomes made of 90% POPC, 10% POPE. (C) Fusion
triggered by biospeciﬁc interactions: Liposomes containing 95% POPC, 5%
biotin-PE fused when 1.67 mM neutravidin was introduced to the chamber
of liposomes. Initially spherical liposomes underwent several fusion events
to form a single giant liposome (right column shows an intermediate stage in
the fusion process). Scale bars ¼ 50 mm. See Supplementary Material for
complete movies of these processes.
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zwitterionic lipids in solutions of CaCl2 (61). Liposomes
adhered at concentrations of CaCl2 between 50 mM to 1 mM
and also at concentrations above 30 mM. Liposomes did not
adhere at concentrations below 10 mM, and they also did not
adhere at concentrations between 1 and 30 mM (61). Marra
and Israelachvili obtained similar results using a direct force
measuring apparatus on adsorbed planar lipid bilayers (62).
Therefore, the results presented here for two-dimensional
aggregation are in agreement with previous measurements of
adhesion energies from Akashi et al. and from Marra and
Israelachvili. With respect to comparing fusion in the two-
dimensional case versus three-dimensional spectroscopic
techniques, however, it is difﬁcult to compare different
fusion assays because several parameters (e.g., sizes of
liposomes, composition of lipids) can drastically affect fusion
(23,25). Most spectroscopic assays employ small and large
unilamellar vesicles (SUVs and LUVs, respectively), which
have signiﬁcantly smaller sizes and higher curvature than
the giant liposomes used here. Wilschut et al. suggested,
however, that the tendency of vesicles to fuse after aggre-
gation induced by Ca21 is related to the tendency of vesicles
to aggregate (63). Since aggregation was comparable be-
tween the assay presented here and previously reported three-
dimensional techniques and since the presented assay shows
that increasing the concentration of fusogenic agents such as
Ca21 increased the fusion probability, we suggest that the
microﬂuidic two-dimensional fusion assay can deliver results
that are at least qualitatively comparable to established fusion
assays.
PEG-induced fusion: effects of
osmotic mismatches
In addition to Ca21-induced fusion, we tested the assay with
PEG. PEG is a hydrophilic polymer that has been employed
to induce fusion of both cells and artiﬁcial vesicles (64). The
well-known mechanism for PEG-triggered fusion derives
from two effects: i), mechanical stress induced by the dif-
ferences in osmolarity across the membranes of liposomes
(65); and ii), dehydration of bilayers by PEG (66). In pre-
vious spectroscopic assays studying PEG-induced fusion,
osmotic mismatches have been used to enhance fusion, as
negative osmotic pressure (when the solution inside lipo-
somes is hypotonic compared to the solution around lipo-
somes, normally associated with shrinkage of liposomes)
promoted fusion of LUVs in the presence of PEG (65).
Using the assay presented here, we ﬁrst examined fusion
of surface-attached giant liposomes after introducing osmot-
ically unmatched solutions of PEG-6000 (at concentrations
of 25 mM, 1 mM, 5 mM, 10 mM PEG-6000). Both 5 mM
and 10 mM PEG induced massive fusion of giant liposomes
(Fig. 2 B). In the case of 10 mM PEG, the liposomes ap-
peared brighter than the surrounding PEG solution within
20 s after introducing 10 mM PEG to surface-attached lipo-
somes; this difference was a result of mismatches in index of
refraction of the PEG solution surrounding liposomes and
the hypotonic solution inside the liposomes (Fig. 2 B, left-
hand side) (45). Immediately after this gray-scale shift, lipo-
somes fused massively with adjacent vesicles (Fig. 2 B,
right-hand side). Concomitantly, the interactions between
membranes increased strongly, and after 75 s, the majority
(.75%) of the liposomes in the ﬁeld of view had fused
(some of these liposomes subsequently ruptured; see Sup-
plementary Movie S2 for the full video of fusion). In contrast
to the massive fusion triggered by 5 mM and 10 mM PEG,
25 mM PEG (a concentration that typically is far too low to
trigger PEG-induced fusion) did not result in fusion or
aggregation of giant liposomes (65).
FIGURE 3 Quantiﬁcation of Ca21-induced two-dimensional aggregation
of surface-attached giant liposomes composed of 100% eggPC. (A) An
image processing algorithm processed the micrographs of giant liposomes
after 1 h of ﬂow of CaCl2 to determine the ‘‘percentage of shared
membrane’’, which represents the average percentage of each liposome that
is in contact with the visible membrane of adjacent liposomes (N ¼ 3 for all
points; error bars represent standard deviations). Images (B–E) show
representative phase-contrast micrographs of two-dimensional aggregation
after introducing solutions of (B) H2O, (C) 500 mM CaCl2, (D) 10 mM
CaCl2, and (E) 200 mM CaCl2 to the liposomes. Note that the liposomes did
not exhibit two-dimensional aggregation after introducing an intermediate
concentration of 10 mM CaCl2. Scale bars ¼ 75 mm.
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In the case of 1 mM PEG-6000, however, giant liposomes
shrank upon introduction of PEG. This shrinkage occurred
on a timescale of minutes, and it was complete after ;20
min. Liposomes did not fuse, and we did not observe in-
creased contacts between giant liposomes. Instead, the giant
liposomes decreased their size such that only a few of them
retained points of contact with neighboring giant liposomes.
We attribute the absence of noticeable shrinkage of lipo-
somes after introducing 5 and 10 mM PEG to the rapid
fusion at these elevated concentrations. Presumably, in these
cases, fusion occurred before signiﬁcant shrinkage (due to
osmotic mismatches) could occur.
We also examined PEG-induced fusion of giant liposomes
using osmotically matched solutions of 1 mM, 5 mM, and
10 mM PEG-6000 (by forming liposomes in solutions of
sucrose isoosmolal to the PEG solution to be introduced, see
Supplementary Material, Fig. S3). With osmotically matched
solutions, we observed that 5 mM and 10 mM PEG induced
rapid fusion of giant liposomes. As expected, with osmot-
ically matched 1 mM PEG, liposomes did not shrink.
Instead, the liposomes experienced two-dimensional aggre-
gation; we did not observe any fusion events within the ﬁeld
of view with 1 mM PEG.
Osmotic mismatches, therefore, can affect the results from
the fusion assay presented here. To explore further the effects
of osmotic mismatches by themselves, we created osmotic
gradients (up to 5 mOsm/kg) with sucrose, a small non-
fusogenic molecule. After introducing 5 mM sucrose to giant
liposomes formed in 0.1 mM Tris, we did not observe any
fusion events or aggregation. Most importantly, surface-
attached giant liposomes did not shrink. Similarly, after
reintroduction of 0.1 mM Tris to the chamber, the liposomes
did not fuse or aggregate.
We attribute the absence of shrinkage or fusion of
liposomes in the case of 5 mM sucrose to the presence of
tubular openings that connect surface-attached giant lipo-
somes to the ﬁlm of lipids on the surface of the ITO electrode
(45,53). Previously we showed that small solutes (including
ions, sucrose, and water) exchanged rapidly through these
tubules into (and out of) surface-attached liposomes; larger
molecules (.3 kDa) did not exchange readily through these
tubules (45). Therefore, as long as we were exchanging low
molecular weight molecules (e.g., Ca21 or sucrose) we
observed only small, transient osmotic mismatches, as the
tubular opening of the liposomes both allowed small mole-
cules to enter liposomes and possibly also relieved osmotic
pressure, thereby minimizing osmotic mismatches. Introduc-
ing 1 mM PEG-6000, however, did generate mismatches that
were signiﬁcant enough to shrink giant liposomes because the
PEG did not exchange rapidly through the lipid tubules.
This example with PEG-6000 highlights several impor-
tant aspects of the fusion assay presented here. First, when
introducing macromolecules (.3 kDa), it is important to
match osmolarities (unless the effects of osmotic mismatches
are intended). For small molecular weight compounds (e.g.,
ions and sucrose) small mismatches in osmolarities do not
cause shrinkage or swelling of vesicles because of lipid
tubules that allow rapid diffusion into surface-attached lipo-
somes. Second, to analyze aggregation and fusion, it is crit-
ically important to establish and maintain sufﬁcient contacts
between liposomes while introducing solutions to the ﬂow
chambers. Since the giant liposomes are surface attached in a
two-dimensional matrix, they have limited lateral mobility to
establish contacts with neighboring liposomes. Liposomes
can either remain as they are, change their shape (e.g., by
two-dimensional aggregation with neighbors), fuse, or shrink.
Therefore, shrinkage of liposomes or examining ﬁelds of view
with sparsely populated liposomes might generate nonrepre-
sentative results since aggregation and fusion cannot occur
if liposomes are spaced too far apart. For the fusion assays
presented here, we always observed densely packed regions of
giant liposomes (Fig. S4), and we only observed shrinkage of
liposomes in the one case of introducing an unmatched
solution of 1 mM PEG-6000. Despite these considerations, the
presented aggregation and fusion assays are typically straight-
forward to perform since electroformation of giant liposomes
from spin-coated ﬁlms of lipids typically results in a dense
two-dimensional network of surface-attached liposomes (45,46)
and since matching osmolarities circumvents the problem of
liposome shrinkage.
Fusion triggered by biospeciﬁc interactions
We utilized the strong binding interactions between biotin
and neutravidin for triggering fusion and thus tested the micro-
ﬂuidic fusion assay on a reconstituted, minimal model of
protein-mediated fusion. We formed surface-attached lipo-
somes containing a biotinylated lipid and ﬂowed a solution
of 1.67 mM neutravidin in deionized water into the chamber
(Fig. 2 C). Liposomes started to fuse immediately with their
neighbors. This lateral fusion proceeded over 25 min until
most liposomes (;80%) in the ﬁeld of view had merged into
one, large liposome with a diameter .600 mm (see Sup-
plementary Movie S3 for a full movie of this fusion process).
No lateral fusion of membranes occurred in a control exper-
iment in which neutravidin was introduced to liposomes that
did not contain biotin-PE.
The mechanism for this fusion process stems from bio-
speciﬁc interactions between adjacent membranes. Neutra-
vidin has four binding sites with high afﬁnity for biotin
(67–69). When introduced to liposomes containing biotin-
PE lipids, neutravidin presumably bound between adjacent
liposomes, thus bringing the membranes into close contact.
Once in contact, the membranes fused possibly due to the
dehydration of membranes or from formation of defects by a
large number of bridging molecules; several research groups
showed previously that such defects can promote fusion
(70–73). This neutravidin-driven mechanism may be con-
sidered as a minimal model of protein-mediated fusion in
cells, such as fusionmechanisms based on SNARE complexes
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(13,59,60). Liposome fusion by biotin-neutravidin interac-
tions also complements studies of fusion of liposomes with
complementary DNA on the headgroups of their lipids (39).
The microﬂuidic fusion assay presented here makes it
straightforward to investigate such minimalist models of
biological fusion events, while providing the opportunity to
increase the complexity of the model by introducing ad-
ditional molecules.
Fusion assay for the WT-B5 peptide, which is
involved in viral entry of herpes simplex virus
To demonstrate the usefulness of the presented microﬂuidic
setup for characterizing novel, biologically relevant fusion
processes, we performed a fusion assay with a 30-amino acid
peptide (WT-B5 peptide) from the C-terminus of B5, a cell-
surface membrane receptor protein that enables viral entry of
HSV into host cells (52,74). The presence of synthetic WT-
B5 peptide blocks HSV infection in human and other B5-
expressing cells by competitive inhibition (52). Moreover,
Perez et al. showed that high concentrations (;42 mM) of
WT-B5 peptide was capable of fusing adjacent cells even in
the absence of proteins from HSV (52). Here, we investi-
gated the fusogenic activity of WT-B5 peptide on adjacent
giant liposomes. This assay had the beneﬁt that it proceeded
under well-deﬁned conditions of, e.g., membrane compo-
sition, buffer composition, and peptide concentration; we
hypothesized, therefore, that it may make it possible to
elucidate the contributions of individual molecules to the
overall fusion event during viral entry of HSV.
We introduced WT-B5 peptide at concentrations between
0.5 and 25.0 mM to surface-attached giant liposomes. WT-
B5 peptide induced fusion of giant liposomes, with a prob-
ability of fusion that was concentration dependent (Fig. 4 A
and SupportingMovie S4).Maximal fusion occurred at 10mM
WT-B5 peptide, where the probability of fusion was 9.7%.
Although a fusion probability below 10% was moderate,
two-dimensional aggregation of membranes in the presence
of the peptide occurred for all liposomes (Fig. 4 B). Even at
0.5 mMWT-B5 peptide, a concentration at which fusion was
very rare, we observed signiﬁcantly increased membrane-
membrane interactions.
The rate of this two-dimensional liposome aggregation
depended on the concentration of WT-B5 peptide. At 25 mM
WT-B5 peptide, most (75%) of membranes deformed within
200 s across the entire ﬁeld of view; at 0.5 mM, liposomes
interacted gradually over the course of 1 h (ﬂow rate for all
concentrations: 2.6 mL h1). Interestingly, this aggregation
was not reversible by ﬂowing isoosmolar solutions of PBS
through the chamber over the course of 2 h. This result indi-
cated that a strong interaction occurs between WT-B5 peptide
and adjacent liposome membranes composed of 90% POPC
and 10% POPE.
We compared these results with fusion induced by two
other short peptides with lengths and physicochemical
properties similar to WT-B5 peptide (Table 1): ACTH (1–24);
and the oxidized chain B of insulin (30 amino acids). The
two control peptides each contained predicted regions of helix
formation (similar to WT-B5 peptide, Table 1) (74–76).
Utilizing the same experimental conditions as in studies of
WT-B5 peptide, we found that these two peptides rarely
triggered fusion of membranes (Fig. 4). We did, however,
observe increased interactions between giant liposomes after
introducing 5 mM concentrations of both the oxidized chain
B of insulin and ACTH (1–24). ACTH (1–24) caused rapid
deformation of membranes, and insulin chain B produced a
more gradual interaction II than ACTH. Interestingly, this
two-dimensional aggregation was reversible for both 5 mM
ACTH (1–24) and 5 mM insulin chain B by ﬂowing
isoosmolar solutions of PBS through the chambers to ﬂow
out the peptide solutions. This result contrasts with irrevers-
ible membrane aggregation with 5 mMWT-B5 peptide under
the same conditions, as mentioned above.
The results of this fusion assay for WT-B5 peptide suggest
several characteristics about the interaction of this peptide
with membranes. First, WT-B5 peptide interacts strongly
with membranes of zwitterionic phospholipids such as
PC and PE, possibly by partial insertion into these mem-
branes. Second, membrane aggregation due toWT-B5 peptide
was irreversible within 2 h, whereas this two-dimensional
FIGURE 4 Fusion assay for WT-B5 peptide compared with control
peptides using giant liposomes composed of 90% POPC, 10% POPE. (A)
We measured the average probability of fusion (deﬁned as the number of
liposomes that fused divided by the total number of liposomes in the ﬁeld of
view) for different concentrations of (n) WT-B5 peptide, (d) ACTH (1–24),
and (:) the oxidized chain B of insulin. For WT-B5 peptide, the fusion
probability was concentration dependent and enhanced compared to the
control peptides. (B) The introduction of 5-mM WT-B5 peptide to initially
spherical liposomes triggered the fusion of up to 10% of liposomes. The
panels in B show a close-up of one of the fusion events at t ¼ 30 s followed
by increased interactions of membranes and two-dimensional aggregation
over the course of the next 770 s. Scale bar ¼ 40 mm.
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aggregation was reversible when induced by control pep-
tides. Previous studies have indicated that other fusion
peptides, such as HA, insert into bilayers and disrupt the
packing of lipids (63,77). The observation that WT-B5
peptide induced fusion at a signiﬁcantly higher probability
than the control peptides supports the hypothesis that WT-B5
peptide inserts into membranes, whereas the control peptides
appeared to associate peripherally or insert weakly into the
membranes of liposomes (78–80).
A second implication of the results with WT-B5 peptide,
which has been documented for other fusion peptides and
molecules, is that aggregation of membranes induced by
WT-B5 peptide is not sufﬁcient to induce a high probability
of fusion (81). Although almost all membranes aggregated at
concentrations of WT-B5 peptide above 1 mM, the proba-
bilities of fusion remained below 10%. Both control peptides
also induced the two-dimensional aggregation of membranes
but did not trigger fusion. Presumably, aggregation was due
to dehydration of membranes combined with neutralization
of surface charges on liposomes (from negatively charged
impurities in PC lipids which are usually present) (55,63),
and the formation of fusogenic defects was rare.
Finally, the results from this assay suggest that WT-B5
peptide by itself does not constitute the complete machinery
necessary for effective viral fusion of HSV. Although WT-
B5 peptide was successful in inducing some fusion of giant
liposomes, these events were not as efﬁcient as examples
involving Ca21 or biospeciﬁc tethering. Although the prob-
abilities of fusion for 25 mM WT-B5 peptide were higher
than for 25 mM PEG-6000, they were signiﬁcantly lower
than the probabilities for 25 mM Ca21 or 1.67 mM neu-
travidin. It is likely that the addition of viral ligands or host
cell proteins to the system would increase the probabilities of
fusion. We believe that the ﬂuidic assay presented here will
be useful for the step-by-step reconstruction of parts of the
fusion machinery of a range of fusion processes.
CONCLUSIONS
The capability to form closely packed giant liposomes that
are attached to the surface of a ﬂow chamber made it possible
to develop a versatile and practical fusion assay. In this
assay, possible fusogenic agents could be introduced into the
chamber, and the fusogenic effects of these molecules could
be observed on many membrane-membrane contacts in par-
allel. In addition, the microﬂuidic setup allowed exchang-
ing solutions inside the chambers, leading to replacement of
solutions both outside and inside surface-attached giant
liposomes (45). This exchange of solutions allowed control-
ling the microenvironment around liposomes, making it pos-
sible to investigate membrane aggregation and fusion in a
range of solutions with varying properties such as ionic
strength (45), pH, or the presence of soluble molecules,
peptides, proteins, etc.
Using this assay, we demonstrated that microﬂuidic assays
of liposome fusion can reveal quantitative information on the
probability of membrane fusion triggered by four different
stimuli, including i), divalent cation-induced aggregation
and destabilization of membranes; ii), dehydration of mem-
branes by PEG; iii), receptor-mediated interactions between
membranes; and iv), fusion promoted by a peptide involved
in viral entry of HSV. Visualization of membrane fusion
provided at least four advantages for studying membrane
fusion. First, visualization was advantageous for studying
the changes in shape of individual liposomes before fusion
(e.g., two-dimensional aggregation, Fig. 3). Second, the
fusion assay presented here provided information about
the individual size of each liposome that fused, as well as the
time after introduction of the fusogenic agent. Third, using
surface-attached giant liposomes may allow monitoring
changes in the shapes of liposomes during the fusion
process. In a recent article, Lei and MacDonald used high-
speed microﬂuorescence spectroscopy to study intermediate
lipid-mixing structures in the fusion of giant liposomes (40).
It is conceivable that high-speed phase-contrast microscopy
techniques could reveal useful information about the changes
in shape of giant liposomes in response to introduced
fusogenic agents before and during fusion, using the assay
presented here. And fourth, being able to observe the fusion
process provided information about the mechanism of fusion
events. In the case of the WT-B5 peptide, the concentration-
dependent, irreversible two-dimensional aggregation of
TABLE 1 Sequence and structural properties of the peptides employed in fusion assay
Name of peptide Sequence Charge *
Average index of
hydrophobicity * Predicted structure in H2O
WT-B5 peptide KQQWQQLYDTLNAWKQN-
LNKVKNSLLSLSD
12 2.7 Predicted a-helix and coiled-coil
formation (52,74)
Oxidized chain B
of insulin
FVNQHLCoxGSHLVEALYL-VCoxGERGF-
FYTPKA
0 0.8 Central a-helix (9–17) with well-deﬁned
b-turn (17–21) (76)
ACTH (1–24) SYSMEHFRWGKPVGKKR-RPVKVYP 16 2.7 Hydrophobic regions (1–10) partition
into POPC membrane (with potential
helical structure), charged regions
(11–24) associate with membrane
surface (75)
*Charge and average index of hydrophobicity were computed using SAPS (statistical analysis of protein sequences) (82).
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membranes indicated that this peptide interacts strongly with
and possibly partitions into bilayers. This interaction was
sufﬁcient to induce fusion of giant liposomes but not to the
extent to conclude that WT-B5 peptide by itself is a highly
efﬁcient fusion peptide.
Despite these numerous advantages, several aspects of this
assay could be further improved. The current methods that we
used for quantifying fusion required detecting and measuring
fusion events visually, and this analysis can be time con-
suming. We believe, however, that image processing algo-
rithms can be developed (perhaps similar to the algorithms
we present in the Supplementary Material to quantify two-
dimensional aggregation) to detect fusion in an automated
procedure to simplify and accelerate the analysis. Also, the
assay in its present form does not reveal quantitative in-
formation on lipid and contents mixing, two parameters that
can provide kinetic information in spectroscopic assays (27).
Therefore, existing spectroscopic techniques may currently
offer rapid means to quantify fusion, whereas the assay
presented here enables direct visualization of fusion events or
aggregation of cell-sized giant vesicles. We believe that
triggering and observing membrane fusion in microﬂuidic
chambers provides a broadly applicable and straightforward
procedure for performing fusion assays on cell-sized lipo-
somes under well-deﬁned and variable conditions.
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